Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 86 filings·Updated 19 Aug 2026
Showing 10 of 86 filings.
19 Aug 20262 filings
Company UpdateChange in Management

DCM Shriram appoints two Independent Directors Kaul and Chatterjee; AGM approvals effective 9 Aug 2026

Appointment: Justice (Retd.) Sanjay Kishan Kaul (Independent Director)

  • Reason: Appointment as Independent Director; five-year term from 9 Aug 2026; AGM approved on 18 Aug 2026.
  • Profile: Former Supreme Court Judge; ex-Chief Justice of Delhi, Punjab & Haryana, Madras High Courts.
  • Relationship: Not related to any other director.

Appointment: Ms. Rumjhum Chatterjee (Independent Director)

  • Reason: Appointment as Independent Director; five-year term from 9 Aug 2026; AGM approved on 18 Aug 2026.
  • Profile: Co-founder of Infravision Foundation; infrastructure policy and CSR advocate.
  • Relationship: Not related to any other director.
Filed 18:18View Source
AGM/EGMAGM

AGM held via VC/OAVM with all resolutions passed by majority

AGM Details

  • AGM held via VC/OAVM with remote and online voting; all resolutions passed by the required majority.
Filed 17:47View Source
18 Aug 20261 filing
AGM/EGMAGM

DCM Shriram conducts 37th AGM via VC/OAVM; approves financials, dividend, and director appointments.

AGM Details

  • AGM held on 18 August 2026 at 10:30 A.M. IST via VC/OAVM.

Key Resolutions

  • Item 1 (Ordinary): Adoption of standalone and consolidated financial statements for FY 2026.
  • Item 2 (Ordinary): Final dividend of Rs 4 per equity share; interim dividends of Rs 3.60 paid.
  • Item 3 (Ordinary): Re-appointment of Ajit S. Shriram as Director (retiring by rotation).
  • Item 4 (Ordinary): Re-appointment of Pradeep Dinodia as Director (retiring by rotation).
  • Item 5 (Ordinary): Ratification of remuneration of Cost Auditors for FY 2025-26.
  • Item 6 (Special): Appointment of Justice (Retd.) Sanjay Kishan Kaul as Independent Director for five years.
  • Item 7 (Special): Appointment of Ms. Rumjhum Chatterjee as Independent Director for five years.
  • Item 8 (Ordinary): Cancellation of 3,900,000 forfeited equity shares.
  • Item 9 (Ordinary): Remuneration increase for Varun Shriram to Rs 1.80 crores p.a. from Apr 2027.
  • Item 10 (Ordinary): Remuneration increase for Tara Shriram to Rs 1.0 crore p.a. from Apr 2026.

Dividend & Remuneration

  • Final dividend declared: Rs 4 per equity share; interim dividends of Rs 3.60 already paid.

Director Changes

  • Re-appointment of Ajit S. Shriram as Director (retiring by rotation).
  • Re-appointment of Pradeep Dinodia as Director (retiring by rotation).
  • Appointment of Justice (Retd.) Sanjay Kishan Kaul as Independent Director for five years.
  • Appointment of Ms. Rumjhum Chatterjee as Independent Director for five years.

Audit & Compliance

  • No qualifications or modifications in Statutory/Secretarial Auditors’ Reports for FY2026.

E-Voting & Meeting Timing

  • Remote e-voting open Aug 14–17, 2026; voting continued 30 minutes after meeting.
Filed 13:17View Source
14 Aug 20261 filing
Company UpdateNewspaper Publication

Special Window for re-lodgement of transfer requests of physical shares

Filed 13:16View Source
8 Aug 20261 filing
Company UpdateChange in Directorate

DCM Shriram announces cessation of two Independent Directors after second term, effective 9 August 2026

Independent Directors cessation

  • Cessation of Pravesh Sharma as Independent Director effective 9 August 2026 after second term.
  • Cessation of Justice (Retd.) Vikramajit Sen as Independent Director effective 9 August 2026 after second term.
  • Both directors cease to be Member/Chairman of their board committees.
Filed 19:36View Source
5 Aug 20261 filing
Company UpdateEarnings Call Transcript

DCM Shriram Q1 FY27: PAT Rs 693 crore including one-time tax gains; ex-one-time PAT Rs 147 crore, up 28%; debt Rs 1,649 crore; renewable-energy and demerger progress.

Financial Performance

  • Chemicals revenue grew 33% YoY; caustic soda volumes steady, ECU prices up 7%.
  • PBDIT in Chemicals rose 24% to INR 274 crore due to higher volumes.
  • Vinyl PBDIT jumped 88% to INR 43 crore; capacity utilization at 100%.
  • Sugar and Ethanol segment revenue fell 2% YoY; PBDIT INR 22 crore.
  • Bioseed PBDIT negative INR 9 crore; revenue declined 26% YoY.
  • PAT for quarter was INR 693 crore; ex-one-time PAT INR 147 crore, up 28%.

Operating Update

  • Fenesta revenue up 22% YoY; PBDIT INR 40 crore; order book around INR 1,000 crore.
  • Shriram Farm Solutions revenue INR 357 crore; PBDIT INR 30 crore.
  • Fertilizer revenues up 11% YoY; PBDIT INR 23 crore; subsidy outstanding INR 292 crore.
  • Bioseed revenue declined 26% YoY; PBDIT negative INR 9 crore.

Balance Sheet and Cash Flow

  • Net debt Rs 1,649 crore as on 30 Jun 2026; Rs 1,481 crore as on 30 Jun 2025.
  • Return on capital employed stood at 13.6% as on Jun 2026 vs 13.2% prior year.
  • Debt to EBITDA not to breach 1.5; currently around 1.1.

Projects and Capex

  • Definitive Serentica Renewables agreement to source 58 MW peak hybrid energy.
  • Total peak renewable capacity across Bharuch and Kota to ~176 MW on commissioning.
  • Kota 68 MW peak renewable project under commissioning; July average injection ~25 MW.
  • Bharuch site received Lighthouse recognition from World Economic Forum.

Outlook and Guidance

  • No formal full-year guidance provided; price outlook remains uncertain due to geo-political factors.

Q&A Highlights

  • ECU price currently just below INR 30,000; prices expected in this range or higher.
  • SFS profitability aided by better realizations and farmer reach despite monsoon headwinds.
  • Tax reversal includes one-time INR 474 crore adjustment; MAT credit INR 376 crore.
  • Cash tax rate around 19% due to MAT; P&L tax rate 25%.
  • Demerger objective to file government application within this financial year.
  • Monsoon impact on Bioseed remains; sowing regional variance 15-20% lower.
Filed 15:42View Source
30 Jul 20261 filing
Company UpdateAnalyst / Investor Meet

DCM Shriram posts audio recording of Q1 FY27 earnings call for analysts

Meeting Details

  • Date and time: 30 July 2026, 4:00 PM IST.
  • Type and mode: group analysts/investors call; virtual audio conference.
  • Event: Earnings Conference Call for Q1 FY27 (standalone & consolidated).
  • Recording: audio recording uploaded on company website.

Participants

  • Company Secretary & Compliance Officer to oversee proceedings.

Purpose

  • Discuss unaudited standalone and consolidated results for quarter ended 30 June 2026.

Additional Notes

  • Audio recording uploaded to the company website.
Filed 19:12View Source
29 Jul 20261 filing
Company UpdateNewspaper Publication

Newspaper Publication

Filed 17:08View Source
28 Jul 20262 filings
Company UpdatePress Release / Media Release

DCM Shriram posts 9% revenue growth and 12% rise in PBDIT in Q1 FY27 (consolidated)

Financial highlights

  • Net revenue (net of excise) ₹3,564 crore, up 9% YoY.
  • PBDIT ₹364 crore, up 12% YoY.
  • PAT ₹693 crore, vs ₹114 crore prior year; includes ₹474.3 crore tax adjustment and ₹79.4 crore one-time items.
  • Excluding adjustments, effective normal PAT ₹147 crore.

Segment performance

  • Chemicals revenue up 33% YoY; Fenesta Building Systems up 22%.

PBDIT contributions

  • Chemicals & Vinyl segment PBDIT up 30%.

Capex and outlook

  • Major capex cycles moving into commissioning phase; focus on capacity ramp-up.
  • Balance sheet remains strong; emphasis on disciplined capital allocation.
  • Sustainability integrated into growth strategy; energy efficiency across manufacturing footprint.

Operating highlights

  • Fenesta and Shriram Farm Solutions strengthened market position; inventory and logistics managed.
  • Aluminum Chloride and Calcium Chloride projects in pre-commissioning trials.
Filed 17:42View Source
Company UpdateInvestor Presentation

DCM Shriram Q1 FY27 results: revenue ₹3,564 Cr; PBDIT ₹364 Cr; PAT ₹274 Cr; capex ramp and acquisitions

Business Overview

  • Diversified, integrated group across Agri value chain, Chemicals & Vinyl, and Building Material Products.

Key Operational Highlights

  • Q1 FY27 revenue ₹3,564 Cr; PBDIT ₹364 Cr; PAT ₹274 Cr.
  • Revenue up 9% YoY; PBDIT up ~15% YoY.
  • Order book increased by 4% in the quarter.
  • Capex: 850 TPD Caustic expansion at Bharuch; 52,500 TPA H2O2 plant at Bharuch.
  • Acquired 53% stake in DNV Global Pvt Ltd; HSCL acquired; FR capacity expanded 36 KTPA.
  • Salt works project of 208,000 MTPA under regulatory approvals.
  • Renewables: 68 MW Kota captive; 58 MW Bharuch capacity via Serentica.
  • Pre-commissioning trials for Aluminium Chloride and Calcium Chloride.

Financial Performance

  • Consolidated revenue ₹3,564 Cr; PBDIT ₹364 Cr; PAT ₹274 Cr for Q1 FY27.
  • Segment mix driven by Chemicals & Vinyl, Fenesta, and Farm Solutions.
  • Capex focus on Bharuch expansions, HSCL, and DNV acquisitions.

Capital Structure & Liquidity

  • Credit rating AA+/Stable (ICRA).
  • Liquidity supported by a strong balance sheet; capex funded from internal accruals.

Strategic Priorities & Outlook

  • Capex ramp transitioning to commissioning; focus on capacity ramp-up and disciplined capital allocation.
  • Outlook: domestic sugar demand firm; Fenesta expansion; ethanol blending policy interventions needed.
  • Fenesta footprint: 8 fabrication plants, 430 dealers, 7 countries.

Risks & Mitigation

  • Geopolitical tensions and energy price volatility; monsoon uncertainty.
  • Mitigation: cost competitiveness and manufacturing flexibility.

Governance & Leadership

  • Management commentary provided by Chairman Ajay Shriram and MD Vikram Shriram; no board changes disclosed.
Filed 17:33View Source
Showing 10 of 86 filings